Rankings
▼
Calendar
BCYC (Bicycle Therapeutics plc) Stock Financials & Earnings | Market Cap Arena
BCYC
Bicycle Therapeutics plc
Mkt Cap
$374M
Healthcare
·
Biotechnology
·
🇬🇧 United Kingdom
·
NASDAQ
Revenue (TTM)
$28M
Net Income (TTM)
-$251M
EPS (TTM)
-$3.61
Free Cash Flow (TTM)
-$242M
Gross Margin
-550.6%
Op. Margin
-1023.4%
Net Margin
-884.5%
FCF Margin
-854.7%
P/S Ratio (TTM)
13.2x
P/E Ratio (TTM)
—
YoY Rev Growth
-23.2%
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$3M
$3M
-$32M
Q1 23
$5M
$5M
-$42M
Q2 23
$11M
$11M
-$43M
Q3 23
$5M
$5M
-$51M
Q4 23
$5M
$5M
-$54M
Q1 24
$20M
$20M
-$32M
Q2 24
$9M
$9M
-$47M
Q3 24
$3M
-$43M
-$64M
Q4 24
$4M
-$52M
-$68M
Q1 25
$10M
-$47M
-$70M
Q2 25
$3M
-$68M
-$87M
Q3 25
$12M
$12M
-$66M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q4 22
25.9x
—
Q1 23
24.1x
—
Q2 23
16.6x
—
Q3 23
15.1x
—
Q4 23
13.9x
—
Q1 24
9.0x
—
Q2 24
9.5x
—
Q3 24
10.1x
—
Q4 24
10.6x
—
Q1 25
14.5x
—
Q2 25
19.4x
—
Q3 25
13.2x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$30M
-$32M
Q1 23
-$46M
-$49M
Q2 23
$34M
$34M
Q3 23
-$1M
-$2M
Q4 23
-$47M
-$47M
Q1 24
-$71M
-$71M
Q2 24
-$45M
-$45M
Q3 24
-$40M
-$40M
Q4 24
-$9M
-$10M
Q1 25
-$87M
-$87M
Q2 25
-$73M
-$73M
Q3 25
-$71M
-$72M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$1M
Q1 23
$2M
Q2 23
$277K
Q3 23
$502K
Q4 23
$51K
Q1 24
$12K
Q2 24
$420K
Q3 24
$435K
Q4 24
$368K
Q1 25
$606K
Q2 25
$498K
Q3 25
$674K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
-15.5%
+62.4%
Q1 23
+26.8%
+49.5%
Q2 23
+160.3%
+72.1%
Q3 23
+76.1%
+71.2%
Q4 23
+67.4%
+68.3%
Q1 24
+298.9%
+9.7%
Q2 24
-17.9%
+2.8%
Q3 24
-50.0%
+18.5%
Q4 24
-30.4%
+19.8%
Q1 25
-48.9%
+56.5%
Q2 25
-68.8%
+59.8%
Q3 25
+338.5%
+16.2%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$6M
173.9%
Q1 23
$9M
184.7%
Q2 23
$8M
71.9%
Q3 23
$7M
138.8%
Q4 23
$8M
146.5%
Q1 24
$9M
47.5%
Q2 24
$9M
99.0%
Q3 24
$9M
343.9%
Q4 24
$10M
278.7%
Q1 25
$10M
96.3%
Q2 25
$9M
323.1%
Q3 25
$9M
74.7%
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q4 22
$25M
$11M
Q1 23
$32M
$14M
Q2 23
$40M
$15M
Q3 23
$40M
$16M
Q4 23
$45M
$15M
Q1 24
$35M
$16M
Q2 24
$40M
$16M
Q3 24
$48M
$18M
Q4 24
$50M
$21M
Q1 25
$59M
$21M
Q2 25
$71M
$19M
Q3 25
$58M
$19M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$339M
$0
$339M
Q1 23
$294M
$0
$294M
Q2 23
$340M
$0
$340M
Q3 23
$572M
$0
$572M
Q4 23
$526M
$0
$526M
Q1 24
$457M
$0
$457M
Q2 24
$961M
$0
$961M
Q3 24
$891M
$0
$891M
Q4 24
$880M
$0
$880M
Q1 25
$793M
$0
$793M
Q2 25
$721M
$0
$721M
Q3 25
$648M
$0
$648M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
30M
+0.1%
Q1 23
30M
+1.0%
Q2 23
30M
+0.6%
Q3 23
40M
+31.1%
Q4 23
42M
+7.2%
Q1 24
43M
+0.3%
Q2 24
52M
+22.2%
Q3 24
69M
+32.7%
Q4 24
69M
+0.1%
Q1 25
69M
+0.2%
Q2 25
69M
+0.1%
Q3 25
69M
+0.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 16
—
—
FY 17
—
—
FY 18
—
—
FY 19
$192K
72
FY 20
$119K
87
FY 21
$98K
119
FY 22
$61K
236
FY 23
$95K
284
FY 24
$116K
305
marketcaparena.com
